Startup company founded by Washington University scientists acquired by Eli Lilly
Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University School of Medicine to speed the development of treatments for multiple neurodegenerative conditions.
Neuroscientist Ponce named a 2020 Packard fellow
Carlos Ponce, MD, PhD, assistant professor of neuroscience at the School of Medicine, is one of 20 people to receive a 2020 Packard Fellowship for Science and Engineering. Packard fellows are among the nation’s top early-career scientists. Ponce studies how visual recognition works in the brain.
Brain inflammation in Parkinson’s disease focus of $3.2 million grant
Researchers at Washington University School of Medicine have received a grant to study the role of brain inflammation in Parkinson’s disease. The project focuses on whether inflammation aids the spread of Parkinson’s damage throughout the brain.
Hengen awarded $1.8M to study sleep’s contribution to brain function
Keith Hengen, assistant professor of biology in Arts & Sciences at Washington University in St. Louis, received a three-year $1.8 million grant to study the role of sleep and waking behavior in shaping the brain’s neural dynamics. His research will help scientists understand how sleep contributes to healthy cognition and shed light on the mechanisms by which disrupted sleep worsens neurodegenerative and mental health disorders.
Cerebral palsy also has genetic underpinnings
Researchers at Washington University School of Medicine in St. Louis and their colleagues at other institutions have identified mutations in single genes that can be responsible for at least some cases of cerebral palsy.
Experimental drug shows early promise against inherited form of ALS, trial indicates
An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine and other sites.
Stroke survival rates worse in rural areas, study says
An interruption in blood flow to the brain causes a stroke. A new study from Washington University School of Medicine in St. Louis reveals that stroke care in rural areas lags significantly behind that available in urban centers.
Previously undetected brain pulses may help circuits survive disuse, injury
A neuroscientist’s arm cast led him and fellow School of Medicine researchers to find previously undetected neuronal pulses in the human brain that activate after an immobilizing illness or injury. The pulses appeared on MRI scans used to measure brain activity.
$3.7 million aimed at studying effect of manganese exposure on cognitive skills
Researchers at Washington University School of Medicine in St. Louis have received a $3.7 million grant to investigate the link between manganese and cognitive problems by studying welders whose work exposes them to the metal.
$13.7 million to further adolescent brain development study
Washington University scientists will receive $13.7 million in additional funding for ongoing research into adolescent brain development. Their work is part of the largest long-term study of brain development ever conducted in the United States.
Older Stories